You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

 

PRODUCT PORTFOLIO

HEMATOLOGY/HEMOPHILIA

EMOCLOT/Koate-DVI*/EMOWIL/HUMACLOT**/PLASMACLOT
Factor VIII/von Willebrand Factor concentrate

NUWIQ***
Recombinant Factor VIII

WILFACTIN***       
Von Willebrand Factor concentrate

WILATE***
Factor VIII/von Willebrand Factor concentrate in combination

AIMAFIX/KEDRIFIX
Factor IX concentrate

EMOSINT       
DDAVP Desmopressin

UMAN COMPLEX/ PRONATIV*** 
Prothrombin Complex concentrate

IMMUNOLOGY/NEUROLOGY

Ig VENA/HUMAGLOBIN Liquid**/KEDRIGAMMA/Gammaked*
Standard i.v. Immunoglobulin

NAXIGLO
Standard s.c. Immunoglobulin  

VENBIG/KEYVENB                       
Anti-hepatitis B i.v. Immunoglobulin 

IMMUNOHBs/UMAN BIG                   
Anti-hepatits B i.v. Immunoglobulin  

TETANUS GAMMA/TETIG**                      
Anti-tetanus i.m. Immunoglobulin              

ImmunoRHO/RhoGAM/MICRhoGAM/KeyRho           
Anti-D i.m. Immunoglobulin

CRITICAL CARE

UMAN ALBUMIN/UMAN SERUM/KALBI/ALBUMINA LFB/HUMAN ALBUMIN/KEDRIALB/PLASBUMIN/KEDBUMIN*/Albuked*
Human Albumin solution

AT III KEDRION   
Antithrombin concentrate

K FLEBO***   
Potassium aspartate

PLASMASAFE***   
Pharmaceutical grade plasma

SILKETAL
Fibrin Sealant

ORPHAN DRUGS

Kedrion Human Plasminogen: a sterile human plasma derived plasminogen preparation in the pharmaceutical form of an eye drop solution for the treatment of Ligneous Conjunctivitis (currently under development product).
At the moment the product obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). The clinical trial is still ongoing for the Marketing Authorization approval in the USA and in Europe (EU).

Products dedicated to the national self-sufficiency program in Italy

VENITAL
Standard i.v. Immunoglobulin      

KEYCUTE
Standard s.c. Immunoglobulin

ALBITAL
Human Albumin solution               

ATKED          
Antithrombin concentrate              

PLASMAGRADE        
Pharmaceutical grade plasma               

KLOTT                
Factor VIII concentrate               

IXED         
Factor IX concentrate              

KEDCOM   
Prothrombin Complex concentrate           

KEDHBs               
Anti-hepatits B i.m. immunoglobulin           

KOLFIB
Fibrin Sealant

Medical devices

CERUS INTERCEPT Small Volume platelets processing set***

CERUS INTERCEPT Large Volume platelets processing set***

CERUS INTERCEPT Plasma processing set***

*** products distributed by Kedrion only for the Italian market
** products only available for the Hungarian market
* products only available for the US market